Abstract:Mechanical force exerted on cancer cells by their microenvironment have been reported to drive cells toward invasive phenotypes by altering cells' motility, proliferation, and apoptosis. These mechanical forces include compressive, tensile, hydrostatic, and shear forces. The importance of forces is then hypothesized to be an alteration of cancer cells' and their microenvironment's biophysical properties as the indicator of a tumor's malignancy state. Our objective is to investigate and quantify the correlation between a tumor's malignancy state and forces experienced by the cancer cells and components of the microenvironment. In this study, we have developed a multicomponent, three-dimensional model of tumor tissue consisting of a cancer cell surrounded by fibroblasts and extracellular matrix (ECM). Our results on three different organs including breast, kidney, and pancreas show that: A) the stresses within tumor tissue are impacted by the organ specific ECM's biophysical properties, B) more invasive cancer cells experience higher stresses, C) in pancreas which has a softer ECM (Young modulus of 1.0 kPa) and stiffer cancer cells (Young modulus of 2.4 kPa and 1.7 kPa) than breast and kidney, cancer cells experienced significantly higher stresses, D) cancer cells in contact with ECM experienced higher stresses compared to cells surrounded by fibroblasts but the area of tumor stroma experiencing high stresses has a maximum length of when the cancer cell is surrounded by fibroblasts and for when the cancer cell is in vicinity of ECM. This study serves as an important first step in understanding of how the stresses experienced by cancer cells, fibroblasts, and ECM are associated with malignancy states of cancer cells in different organs. The quantification of forces exerted on cancer cells by different organ-specific ECM and at different stages of malignancy will help, first to develop theranostic strategies, second to predict accurately which tumors will become highly malignant, and third to establish accurate criteria controlling the progression of cancer cells malignancy. Furthermore, our in silico model of tumor tissue can yield critical, useful information for guiding ex vivo or in vitro experiments, narrowing down variables to be investigated, understanding what factors could be impacting cancer treatments or even biomarkers to be looking for.

Understanding and measuring mechanical signals in the tumor stroma

The Role of Matrix Stiffness in Cancer Stromal Cell Fate and Targeting Therapeutic Strategies

Three-Dimensional Measurement of the Mechanical Fields and Fiber Structure Around Cancer Cells Co-Cultured with CAFs

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer

Mechanical properties of the tumor stromal microenvironment probed in vitro and ex vivo by in situ-calibrated optical trap-based active microrheology

Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers

Measuring mechanical cues for modeling the stromal matrix in 3D cell cultures

The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression

Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy

Modeling Physical Forces Experienced by Cancer and Stromal Cells Within Different Organ-Specific Tumor Tissue

Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment

Beyond stiffness: deciphering the role of viscoelasticity in cancer evolution and treatment response

Targeting extracellular matrix stiffness for cancer therapy

Changes in Tissue Fluidity Predict Tumor Aggressiveness In Vivo

Cancer-Associated Fibroblasts in a 3D Engineered Tissue Model Induce Tumor-like Matrix Stiffening and EMT Transition

Multiple aspects of matrix stiffness in cancer progression

Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells

Fibrosis and cancer: A strained relationship

Mechanical Studies of the Third Dimension in Cancer: From 2D to 3D Model

Fight the Cancer, Hit the CAF!

Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets